Future Innovations

The following publications have been written and published by researchers, clinicians or companies independent from Heidelberg Engineering. The uses of the devices or modules as described in these publications are not part of the intended use of the products. The interest of Heidelberg Engineering in this publications is to support scientific research to discover innovative imaging applications to improve patient care. We are not aware of any other financial interest, compensation, or funding for these studies. There are no significant risks or safety concerns known concerning the unapproved use discussed in the publications.

Optical coherence tomography (OCT) in unconscious and systemically unwell patients using a mobile OCT device: a pilot study

Please find an investigational study from the University of Birmingham on the SPECTRALIS^® Flex Module. The research study highlights how the Flex Module with its full multimodal imaging capabilities can assist clinicians in diagnosing and monitoring patients in different positions.

by Xiaoxuan Liu, Aditya Uday Kale, Nicholas Capewell, Nicholas Talbot, Sumiya Ahmed, Pearse A Keane, Susan Mollan, Antonio Belli, Richard J Blanch, Tonny Veenith, Alastair K Denniston

• Download PDF (1.46Mb)

*The SPECTRALIS Flex Module has not been approved or cleared by FDA. Furthermore, the use of the module as described in this publication is not part of the intended use of the product. The interest of Heidelberg Engineering in this publication is to support scientific research to discover innovative imaging applications to improve patient care. Heidelberg Engineering has provided a SPECTRALIS Flex Module to University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK. We are not aware of any other financial interest, compensation, or funding for this study. There are no significant risks or safety concerns known concerning the unapproved use discussed in the publication.